Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Revolution Beauty shares spike as Frasers mulls potential bid

(Sharecast News) - Revolution Beauty shares spiked on Monday after it was confirmed that Mike Ashley's Frasers Group was one of a number of parties conducting considering a purchase of the cosmetic retailer.

The stock was up 20% at one point before settling back for a gain of 10% after it emerged that Frasers was "one of a number of parties conducting due diligence" on the business.

Revolution last month announced plans to raise fresh funds and on May 21 said it had received a takeover approach from an unnamed bidder sending its shares soaring by 36% as the board said it would now be "appropriate to investigate" a sale.

Bidders have until June 11 to put forward their interest.

"There can be no certainty that Frasers' interest will result in a firm offer for the company," Revolution told shareholders in a filing on Monday. "Further updates will be provided if and when appropriate. Shareholders are advised to take no action at this time."

The Aim-listed firm listed in 2021 but its market capitalisation is now only £20m after it share price tanked 66% over the past year. It has also been investigated over accounting issues and 27% shareholder Boohoo, which called for Revolution's leadership team to be replaced.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.